Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/TME-PHARMA-N-V-31472058/news/NOXXON-Pharma-N-SCHLIESST-6-MONATIGE-THERAPIE-FUR-NIEDRIGDOSIS-KOHORTE-IN-DER-PHASE-1-2-GEHIRNTUM-31627240/?utm_source=whatsapp&utm_medium=social&utm_campaign=share